ArticlePharmaceutics2021

Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy.

Ascensión López-Díaz de Cerio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.